MK-0533

CAS No. 668455-28-5

MK-0533( —— )

Catalog No. M36129 CAS No. 668455-28-5

MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 219 In Stock
10MG 326 In Stock
25MG 523 In Stock
50MG 737 In Stock
100MG 1014 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MK-0533
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    668455-28-5
  • Formula Weight
    527.49
  • Molecular Formula
    C28H24F3NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1N(C=2C(C1C(=O)C3=CC=C(OC)C=C3)=CC=C(OC(F)(F)F)C2)C4=CC(O[C@@H](C(O)=O)CC)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dihydrocurcumin

    Dihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response.

  • Siramesine

    Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.

  • GW 501516

    A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.